{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:23:48Z","timestamp":1792113828269,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03306-1","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T18:31:32Z","timestamp":1768501892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["HPMC Substitution Influences the Buoyancy and Release in Gastroretentive Floating Tablets"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5677-537X","authenticated-orcid":false,"given":"Li Ying","family":"Kam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-196X","authenticated-orcid":false,"given":"Jia Woei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-7629","authenticated-orcid":false,"given":"Kah Hay","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"issue":"4","key":"3306_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1359-6446(04)03351-3","volume":"10","author":"SS Davis","year":"2005","unstructured":"Davis SS. Formulation strategies for absorption windows. Drug Discov Today. 2005;10(4):249\u201357.","journal-title":"Drug Discov Today"},{"issue":"8","key":"3306_CR2","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/gut.27.8.886","volume":"27","author":"SS Davis","year":"1986","unstructured":"Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut. 1986;27(8):886\u201392.","journal-title":"Gut"},{"issue":"5","key":"3306_CR3","first-page":"575","volume":"11","author":"UK Mandal","year":"2016","unstructured":"Mandal UK, Chatterjee B, Senjoti FG. Gastro-retentive drug delivery systems and their in vivo success: a recent update. Asian J Pharm Sci. 2016;11(5):575\u201384.","journal-title":"Asian J Pharm Sci"},{"issue":"5","key":"3306_CR4","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s13346-020-00875-5","volume":"11","author":"S Das","year":"2021","unstructured":"Das S, Kaur S, Rai VK. Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery. Drug Deliv Transl Res. 2021;11(5):1849\u201377.","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"3306_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104340","volume":"30","author":"H Omidian","year":"2025","unstructured":"Omidian H. Gastroretentive drug delivery systems: a holy grail in oral delivery. Drug Discov Today. 2025;30(4): 104340.","journal-title":"Drug Discov Today"},{"issue":"1","key":"3306_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1208\/s12249-010-9380-5","volume":"11","author":"RC Nagarwal","year":"2010","unstructured":"Nagarwal RC, Ridhurkar DN, Pandit JK. In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet. AAPS PharmSciTech. 2010;11(1):294\u2013303.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"3306_CR7","doi-asserted-by":"publisher","first-page":"E372","DOI":"10.1208\/pt060347","volume":"6","author":"S Arora","year":"2005","unstructured":"Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005;6(3):E372\u201390.","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"3306_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3390\/pharmaceutics13101591","volume":"13","author":"NN Vrettos","year":"2021","unstructured":"Vrettos NN, Roberts CJ, Zhu Z. Gastroretentive technologies in tandem with controlled-release strategies: a potent answer to oral drug bioavailability and patient compliance implications. Pharmaceutics. 2021;13(10):1591.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3306_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/pharmaceutics11040193","volume":"11","author":"J Tripathi","year":"2019","unstructured":"Tripathi J, Thapa P, Maharjan R, Jeong SH. Current state and future perspectives on gastroretentive drug delivery systems. Pharmaceutics. 2019;11(4):193.","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"3306_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijpharm.2013.05.011","volume":"452","author":"L Yin","year":"2013","unstructured":"Yin L, Qin C, Chen K, Zhu C, Cao H, Zhou J, et al. Gastro-floating tablets of cephalexin: Preparation and in vitro\/in vivo evaluation. Int J Pharm. 2013;452(1\u20132):241\u20138.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"3306_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijpharm.2015.05.007","volume":"489","author":"X Qi","year":"2015","unstructured":"Qi X, Chen H, Rui Y, Yang F, Ma N, Wu Z. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent. Int J Pharm. 2015;489(1\u20132):210\u20137.","journal-title":"Int J Pharm"},{"issue":"1","key":"3306_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.29208\/jsfk.2017.4.1.201","volume":"4","author":"L Fitriani","year":"2017","unstructured":"Fitriani L, Abdillah R, Ben ES. Formulation of Metformin HCl Floating Tablet using HPC, HPMC K100M, and the Combinations. Jurnal Sains Farmasi & Klinis. 2017;4(1):79.","journal-title":"Jurnal Sains Farmasi & Klinis"},{"issue":"3","key":"3306_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.34172\/apb.2020.048","volume":"10","author":"M Djebbar","year":"2020","unstructured":"Djebbar M, Chaffai N, Bouchal F. Development of floating tablets of metformin HCl by thermoplastic granulation. Part II: in vitro evaluation of the combined effect of acacia gum\/HPMC on biopharmaceutical performances. Adv Pharm Bull. 2020;10(3):399\u2013407.","journal-title":"Adv Pharm Bull"},{"key":"3306_CR14","first-page":"1140","volume":"311\u2013313","author":"S Sungthongjeen","year":"2011","unstructured":"Sungthongjeen S, Sriamornsak P, Puttipipatkhachorn S. Design of floating HPMC matrix tablets: effect of formulation variables on floating properties and drug release. Adv Mat Res. 2011;311\u2013313:1140\u20133.","journal-title":"Adv Mat Res"},{"issue":"1\u20132","key":"3306_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijpharm.2014.09.056","volume":"476","author":"W He","year":"2014","unstructured":"He W, Li Y, Zhang R, Wu Z, Yin L. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro\/in vivo evaluation. Int J Pharm. 2014;476(1\u20132):223\u201331.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"3306_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijpharm.2018.04.011","volume":"545","author":"C Qin","year":"2018","unstructured":"Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y, et al. Design and optimization of gastro-floating sustained-release tablet of pregabalin: in vitro and in vivo evaluation. Int J Pharm. 2018;545(1\u20132):37\u201344.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"3306_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijpharm.2005.12.003","volume":"310","author":"X Xu","year":"2006","unstructured":"Xu X, Sun M, Zhi F, Hu Y. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int J Pharm. 2006;310(1\u20132):139\u201345.","journal-title":"Int J Pharm"},{"issue":"9","key":"3306_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3109\/03639045.2014.956113","volume":"41","author":"Y Gao","year":"2015","unstructured":"Gao Y, Gao Y, Yin F, Wang M, Wang Z, Ye T, et al. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide. Drug Dev Ind Pharm. 2015;41(9):1443\u201351.","journal-title":"Drug Dev Ind Pharm"},{"issue":"6","key":"3306_CR19","doi-asserted-by":"publisher","first-page":"e0126874","DOI":"10.1371\/journal.pone.0126874","volume":"10","author":"A Kadivar","year":"2015","unstructured":"Kadivar A, Kamalidehghan B, Javar HA, Davoudi ET, Zaharuddin ND, Sabeti B, et al. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet. PLoS ONE. 2015;10(6):e0126874.","journal-title":"PLoS ONE"},{"key":"3306_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jddst.2019.02.011","volume":"51","author":"S Wang","year":"2019","unstructured":"Wang S, Wen H, Li P, Cui M, Sun W, Wang H, et al. Formulation and evaluation of gastric-floating controlled release tablets of Ginkgolides. J Drug Deliv Sci Technol. 2019;51:7\u201317.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3306_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejpb.2004.03.006","volume":"58","author":"ML Vueba","year":"2004","unstructured":"Vueba ML, de Batista Carvalho LAE, Veiga F, Sousa JJ, Pina ME. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur J Pharm Biopharm. 2004;58(1):51\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"3306_CR22","doi-asserted-by":"publisher","first-page":"120113","DOI":"10.1016\/j.ijpharm.2020.120113","volume":"592","author":"H Wook Huh","year":"2021","unstructured":"Wook Huh H, Na YG, Kang H, Kim M, Han M, Mai Anh Pham T, et al. Novel self-floating tablet for enhanced oral bioavailability of metformin based on cellulose. Int J Pharm. 2021;592:120113.","journal-title":"Int J Pharm"},{"key":"3306_CR23","doi-asserted-by":"publisher","unstructured":"EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed). Scientific opinion on the safety and efficacy of vitamin B1 (thiamine mononitrate and thiamine hydrochloride) as a feed additive for all animal species based on a dossier submitted by DSM nutritional products. EFSA J. 2011;9(11):2413. https:\/\/doi.org\/10.2903\/j.efsa.2011.2413.","DOI":"10.2903\/j.efsa.2011.2413"},{"key":"3306_CR24","doi-asserted-by":"publisher","first-page":"125177","DOI":"10.1016\/j.molliq.2024.125177","volume":"407","author":"A Kumar","year":"2024","unstructured":"Kumar A, Jindal A. Cytotoxicity and bioavailability assessment from micellar system based Thiamine-Phospholipid complexes. J Mol Liq. 2024;407:125177.","journal-title":"J Mol Liq"},{"key":"3306_CR25","doi-asserted-by":"publisher","unstructured":"Mrowicka M, Mrowicki J, Dragan G, Majsterek I. The importance of thiamine (vitamin B1) in humans. Biosci Rep. 2023;43(10):BSR20230374. https:\/\/doi.org\/10.1042\/BSR20230374.","DOI":"10.1042\/BSR20230374"},{"issue":"4","key":"3306_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1525-1373.2000.22428.x","volume":"224","author":"G Rindi","year":"2000","unstructured":"Rindi G, Laforenza U. Thiamine intestinal transport and related issues: recent aspects. Proc Soc Exp Biol Med. 2000;224(4):246\u201355.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"2","key":"3306_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF02124072","volume":"33","author":"G Rindi","year":"1977","unstructured":"Rindi G, Ferrari G. Thiamine transport by human intestine in vitro. Experientia. 1977;33(2):211\u20133.","journal-title":"Experientia"},{"issue":"1","key":"3306_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1472-6904-12-4","volume":"12","author":"HA Smithline","year":"2012","unstructured":"Smithline HA, Donnino M, Greenblatt DJ. Pharmacokinetics of high-dose oral thiamine hydrochloride in healthy subjects. BMC Clin Pharmacol. 2012;12(1):4.","journal-title":"BMC Clin Pharmacol"},{"issue":"6","key":"3306_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/BF01073936","volume":"18","author":"W Weber","year":"1990","unstructured":"Weber W, Nitz M, Looby M. Nonlinear kinetics of the thiamine cation in humans: Saturation of nonrenal clearance and tubular reabsorption. J Pharmacokinet Biopharm. 1990;18(6):501\u201323.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"1","key":"3306_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13065-021-00773-y","volume":"15","author":"AL Voelker","year":"2021","unstructured":"Voelker AL, Taylor LS, Mauer LJ. Effect of pH and concentration on the chemical stability and reaction kinetics of thiamine mononitrate and thiamine chloride hydrochloride in solution. BMC Chem. 2021;15(1):47.","journal-title":"BMC Chem"},{"issue":"2","key":"3306_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ejpb.2007.12.009","volume":"69","author":"S Str\u00fcbing","year":"2008","unstructured":"Str\u00fcbing S, Abboud T, Contri RV, Metz H, M\u00e4der K. New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Eur J Pharm Biopharm. 2008;69(2):708\u201317.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2\u20133","key":"3306_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0169-409X(01)00112-0","volume":"48","author":"J Siepmann","year":"2001","unstructured":"Siepmann J, Peppas N. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48(2\u20133):139\u201357.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"3306_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263\u201371.","journal-title":"AAPS J"},{"issue":"1","key":"3306_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25\u201335.","journal-title":"Int J Pharm"},{"issue":"1","key":"3306_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release II. fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37\u201342.","journal-title":"J Control Release"},{"issue":"1","key":"3306_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","volume":"27","author":"KA Khan","year":"2011","unstructured":"Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 2011;27(1):48\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20133","key":"3306_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0378-5173(93)90129-4","volume":"97","author":"F Podczeck","year":"1993","unstructured":"Podczeck F. Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT). Int J Pharm. 1993;97(1\u20133):93\u2013100.","journal-title":"Int J Pharm"},{"key":"3306_CR38","first-page":"164","volume":"32","author":"D Brockmeier","year":"1986","unstructured":"Brockmeier D. In vitro\/in vivo correlation of dissolution using moments of dissolution and transit times. Acta Pharm Technol. 1986;32:164\u201374.","journal-title":"Acta Pharm Technol"},{"issue":"3","key":"3306_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF01062525","volume":"20","author":"RD Purves","year":"1992","unstructured":"Purves RD. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). J Pharmacokinet Biopharm. 1992;20(3):211\u201326.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"2","key":"3306_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"key":"3306_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.powtec.2011.12.060","volume":"238","author":"KG Pitt","year":"2013","unstructured":"Pitt KG, Heasley MG. Determination of the tensile strength of elongated tablets. Powder Technol. 2013;238:169\u201375.","journal-title":"Powder Technol"},{"issue":"8","key":"3306_CR42","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/jps.2600660832","volume":"66","author":"MP Summers","year":"1977","unstructured":"Summers MP, Enever RP, Carless JE. Influence of crystal form on tensile strength of compacts of pharmaceutical materials. J Pharm Sci. 1977;66(8):1172\u20135.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3306_CR43","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1208\/s12249-008-9038-8","volume":"9","author":"M Nama","year":"2008","unstructured":"Nama M, Gonugunta CSR, Reddy VP. Formulation and evaluation of gastroretentive dosage forms of clarithromycin. AAPS PharmSciTech. 2008;9(1):231.","journal-title":"AAPS PharmSciTech"},{"key":"3306_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejpb.2017.01.027","volume":"115","author":"KM Hwang","year":"2017","unstructured":"Hwang KM, Cho CH, Tung NT, Kim JY, Rhee YS, Park ES. Release kinetics of highly porous floating tablets containing cilostazol. Eur J Pharm Biopharm. 2017;115:39\u201351.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1\u20132","key":"3306_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0378-5173(01)00583-X","volume":"216","author":"H Ju\u00e1rez","year":"2001","unstructured":"Ju\u00e1rez H, Rico G, Villafuerte L. Influence of admixed carboxymethylcellulose on release of 4-aminopyridine from hydroxypropyl methylcellulose matrix tablets. Int J Pharm. 2001;216(1\u20132):115\u201325.","journal-title":"Int J Pharm"},{"issue":"11","key":"3306_CR46","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/foods10112629","volume":"10","author":"Y Chen","year":"2021","unstructured":"Chen Y, Peng J, Wang Y, Wadhawan D, Wu L, Gao X, et al. Development, characterization, stability and bioaccessibility improvement of 7,8-Dihydroxyflavone loaded zein\/sophorolipid\/polysaccharide ternary nanoparticles: comparison of sodium alginate and sodium carboxymethyl cellulose. Foods. 2021;10(11):2629.","journal-title":"Foods"},{"issue":"19","key":"3306_CR47","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.3390\/polym14194127","volume":"14","author":"X Li","year":"2022","unstructured":"Li X, Tang Z, Sun Z, Simonsen J, Luo Z, Li X, et al. Chemical and enzymatic fiber modification to enhance the mechanical properties of CMC composite films. Polymers (Basel). 2022;14(19):4127.","journal-title":"Polymers (Basel)"},{"issue":"65","key":"3306_CR48","doi-asserted-by":"publisher","first-page":"39722","DOI":"10.1039\/D0RA04316H","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou Z, Zhang B, Nie X, Cheng Y, Hu Z, Liao M, et al. A sodium alginate-based sustained-release IPN hydrogel and its applications. RSC Adv. 2020;10(65):39722\u201330.","journal-title":"RSC Adv"},{"key":"3306_CR49","doi-asserted-by":"publisher","first-page":"114493","DOI":"10.1016\/j.ejpb.2024.114493","volume":"204","author":"M Kakuk","year":"2024","unstructured":"Kakuk M, Alexandra M\u00e9sz\u00e1ros L, Farkas D, Tonka-Nagy P, T\u00f3th B, Nagy ZK, et al. Evaluation of floatability characteristics of gastroretentive tablets using VIS imaging with artificial neural networks. Eur J Pharm Biopharm. 2024;204:114493.","journal-title":"Eur J Pharm Biopharm"},{"key":"3306_CR50","doi-asserted-by":"crossref","unstructured":"Tufail M, Shah KU, Khan IU, Khan KA, Shah SU, Rashid F, Khan J, Alshammari A, Alasmari AF, Riaz MS. Controlled release bilayer floating effervescent and noneffervescent tablets containing levofloxacin and famotidine.\u00a0Int J Polym Sci. 2024; article 1243321.","DOI":"10.1155\/2024\/1243321"},{"key":"3306_CR51","unstructured":"Ram\u00edrez-Campos M, Villafuerte-Robles L. Effect of formulation variables on verapamil hydrochloride release from hydrated HPMC matrices. Rev Soc Qu\u00edm M\u00e9x. 2004;48:326\u201331."},{"key":"3306_CR52","first-page":"575","volume-title":"Transport processes in pharmaceutical systems","author":"MJ Nerurkar","year":"1999","unstructured":"Nerurkar MJ, Duddu S, Grant DJW, Rytting JH. Properties of solids that affect transport. In: Amidon GL, Lee PI, Topp EM, editors. Transport processes in pharmaceutical systems. New York: Marcel Dekker; 1999. p. 575\u2013610."},{"issue":"3","key":"3306_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/pharmaceutics10030161","volume":"10","author":"P Thapa","year":"2018","unstructured":"Thapa P, Jeong S. Effects of formulation and process variables on gastroretentive floating tablets with a high-dose soluble drug and experimental design approach. Pharmaceutics. 2018;10(3):161.","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"3306_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijpharm.2006.02.038","volume":"316","author":"MD Chavanpatil","year":"2006","unstructured":"Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavia PR. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm. 2006;316(1\u20132):86\u201392.","journal-title":"Int J Pharm"},{"issue":"16","key":"3306_CR55","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.3390\/polym14163406","volume":"14","author":"N Hirun","year":"2022","unstructured":"Hirun N, Kraisit P. Drug-Polymers Composite Matrix Tablets: Effect of hydroxypropyl methylcellulose (hpmc) K-series on porosity, compatibility, and release behavior of the tablet containing a BCS class I drug. Polymers (Basel). 2022;14(16):3406.","journal-title":"Polymers (Basel)"},{"key":"3306_CR56","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jconrel.2020.05.045","volume":"324","author":"E Ma\u0161kov\u00e1","year":"2020","unstructured":"Ma\u0161kov\u00e1 E, Kubov\u00e1 K, Raimi-Abraham BT, Vllasaliu D, Vohl\u00eddalov\u00e1 E, Tur\u00e1nek J, et al. Hypromellose \u2013 a traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery. J Control Release. 2020;324:695\u2013727.","journal-title":"J Control Release"},{"key":"3306_CR57","doi-asserted-by":"publisher","first-page":"120731","DOI":"10.1016\/j.carbpol.2023.120731","volume":"311","author":"C Jin","year":"2023","unstructured":"Jin C, Wu F, Hong Y, Shen L, Lin X, Zhao L, et al. Updates on applications of low-viscosity grade Hydroxypropyl methylcellulose in coprocessing for improvement of physical properties of pharmaceutical powders. Carbohydr Polym. 2023;311:120731.","journal-title":"Carbohydr Polym"},{"issue":"6","key":"3306_CR58","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/pharmaceutics17060784","volume":"17","author":"RA Vlad","year":"2025","unstructured":"Vlad RA, Pintea A, Pintea C, R\u00e9dai EM, Antonoaea P, B\u00eersan M, et al. Hydroxypropyl methylcellulose\u2014a key excipient in pharmaceutical drug delivery systems. Pharmaceutics. 2025;17(6):784.","journal-title":"Pharmaceutics"},{"issue":"1\u20133","key":"3306_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0378-5173(93)90085-T","volume":"100","author":"K Mitchell","year":"1993","unstructured":"Mitchell K, Ford JL, Armstrong DJ, Elliott PNC, Hogan JE, Rostron C. The influence of substitution type on the performance of methylcellulose and hydroxypropylmethycellulose in gels and matrices. Int J Pharm. 1993;100(1\u20133):143\u201354.","journal-title":"Int J Pharm"},{"key":"3306_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.colsurfb.2012.11.020","volume":"104","author":"K Asare-Addo","year":"2013","unstructured":"Asare-Addo K, Kaialy W, Levina M, Rajabi-Siahboomi A, Ghori MU, Supuk E, et al. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices\u2014the use of the USP III apparatus. Colloids Surf B Biointerfaces. 2013;104:54\u201360.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"3306_CR61","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0928-0987(99)00054-8","volume":"9","author":"C Gustafsson","year":"1999","unstructured":"Gustafsson C, Bonferoni MC, Caramella C, Lennholm H, Nystr\u00f6m C. Characterisation of particle properties and compaction behaviour of hydroxypropyl methylcellulose with different degrees of methoxy\/hydroxypropyl substitution. Eur J Pharm Sci. 1999;9(2):171\u201384.","journal-title":"Eur J Pharm Sci"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03306-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03306-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03306-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:02:58Z","timestamp":1770318178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03306-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3306"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03306-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report there are no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"77"}}